Definitive Healthcare Corp.

DH Healthcare Health Information Services

Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.

Revenue
−8.99%
EPS
+71.4%
Free cash flow
−32.6%
Total debt
−5.03%

Quarter to September 2026, against a year earlier

1.16 0.03 +2.65%
Market cap
$163.7M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
−1.48
Beneish M
−4.17
Dividend safety
45/100

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 70.56%

Capital & Financial Ratios $m

Size
Market Cap 163.67
Revenue ttm 227.31
Net income ttm (222.36)
Free cash flow ttm 24.19
Net debt Q (31.45)
Valuation
P/E 0.00
Forward P/E 0.00
Price / sales 0.53
Forward P/S Powerpack
Price / FCF 4.99
Price / book 0.64
Financial health
Current ratio Q 1.96 (at or above 1.5: strong)
Debt / equity Q 0.84
Interest coverage Q (1.87)
Growth
Revenue growth Q −8.99% (below 0%: shrinking)
Operating income growth Q +42.84% (above 0%: growing)
EPS, this year −18.54% (below 0%: weak)
EPS, next year A −4.86% (below 0%: weak)
Revenue, next year A +531.48% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A −8.31% (below 0%: weak)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 12.85%
10-year low 10-year high
P/B against its own 10 years 24.61%
10-year low 10-year high
EV/Sales against its own 10 years 10.84%
10-year low 10-year high
EV/FCF against its own 10 years 13.31%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 308 290 181 190
Receivables 59 53 52 30
Inventory — — — —
Other — — — —
394 370 258 244
2023 2024 2025 Q'26
Payables 6 11 4 6
ST’ Debt 14 14 9 9
Other — — — —
171 161 157 124

Compound Annual Growth %

10y 5y 3y
Sales — 15.34% 2.75%
Cash Flow — 18.29% 14.76%
Earnings — 0.00% 0.00%
Book Value — (20.53%) (36.53%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (1.32) (0.05) (0.04) — —
’25 (0.95) (0.07) (0.14) (0.09) (1.30)
’24 (0.08) (1.81) (1.12) (0.51) (3.54)
’23 (0.11) (0.08) (1.50) (0.09) (1.79)
’22 (0.09) (0.05) (0.03) 0.07 (0.06)
’21 (0.07) (0.08) (0.07) (0.11) (0.19)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 56 55 55 — —
’25 59 61 60 62 242
’24 63 64 63 62 252
’23 59 61 65 66 251
’22 50 55 57 61 223
’21 37 40 43 46 166
’20 — 28 30 34 118
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 12 11 11 — —
’25 26 9 16 3 54
’24 17 14 19 8 58
’23 15 12 9 5 41
’22 14 15 11 (4) 36
’21 14 8 (1) 4 25
’20 — 14 1 9 23
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 8 9 9 — —
’25 18 7 13 (2) 37
’24 16 14 19 (3) 46
’23 14 11 9 4 38
’22 13 15 9 (9) 27
’21 10 7 (1) 3 18
’20 — 13 1 8 22
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — 86 118 166 223 251 252 242 227 +18.9% — — — —
Gross margin, % — — — 78.23 74.25 75.51 80.86 81.11 78.30 75.88 75.37 (2.3) pt
EBT — — — (36) (53) (63) (42) (308) (634) (209) (227) +33.8%
EBT margin, % — — — (42.57) (44.46) (37.78) (18.81) (122.58) (251.28) (86.64) (99.73) (44.1) pt
Net income — 0 — (36) (53) (62) (24) (290) (591) (199) (222) n/m
Per share, $
Per share, $ Revenue — — — 0.57 1.22 1.81 2.20 2.23 2.16 2.26 2.13 +25.7%
Earnings — — — (0.24) — (0.19) (0.06) (1.79) (3.54) (1.30) (1.50) +32.5%
Cash flow — — — 0.14 0.24 0.27 0.35 0.37 0.50 0.50 0.35 +23.1%
Capex — — — (0.01) (0.01) (0.07) (0.08) (0.03) (0.11) (0.16) (0.12) +52.0%
Free cash flow — — — 0.13 0.22 0.20 0.27 0.34 0.39 0.35 0.23 +17.5%
Book value — — — 8.16 12.32 16.32 14.66 10.63 5.21 3.55 1.77 (12.9%)
Shares, m — — — 149 97 92 101 113 117 107 106 (5.4%)
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S — — — 45.94 45.94 15.12 5.09 4.55 1.90 1.27 0.53 17.1
P/B — — — 5.50 5.50 1.67 0.76 0.95 0.79 0.81 0.64 2.3
EV/Sales — — — 48.95 48.95 14.42 4.78 4.35 1.71 1.20 0.39 17.8
EV/FCF — — — 267.71 267.71 129.61 39.08 28.60 9.43 7.83 3.69 107.1
Cash, $m
Cash, $m Operating cash flow — — — 22 23 25 36 41 58 54 37 +16.4%
Capex — — — (2) (1) (7) (8) (3) (12) (17) (13) +43.7%
Free cash flow — — — 20 22 18 27 38 46 37 24 +11.1%
Balance, $m
Balance, $m Working capital — — — (34) (25) 321 273 223 209 101 120 n/m
Net debt — — — 431 437 (117) (68) (52) (47) (16) (31) n/m
Shareholders’ equity — — — 1,216 1,196 1,500 1,482 1,199 607 379 188 (17.7%)
Returns, %
Returns, % ROA — — — 0.00 (2.95) (0.92) (0.34) (10.25) (28.34) (15.23) (25.28) (15.2) pt
ROIC — — — (0.68) (0.61) (1.23) (1.95) (17.96) (79.31) (38.62) (95.39) (37.9) pt
ROE — — — 0.00 (4.24) (1.32) (0.48) (15.10) (45.74) (28.18) (54.40) (28.2) pt
People
People Employees — — — — 625 676 974 830 782 686 — +1.9%
Revenue/emp, $m — — — 0.00 0.19 0.25 0.23 0.30 0.32 0.35 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Definitive Healthcare Corp. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CTEV Claritev Corporation $342.7M — (loss-making) — (loss-making) +6.59% (above 0%: growing) n/m +49.10% (above 0%: growing) 73.72% 9.09% Compare
SPOK Spok Holdings, Inc. $245.9M 12.9× 16.2× −2.56% (below 0%: shrinking) +190.31% (above 0%: growing) +61.57% (above 0%: growing) 79.66% 17.08% Compare
AMWL American Well Corporation $208.5M — (loss-making) — (loss-making) −12.96% (below 0%: shrinking) n/m +21.98% (above 0%: growing) 52.99% (23.79%) Compare
SY So-Young International Inc. Sponsored ADR $177.7M — (loss-making) 12.8× +40.84% (above 0%: growing) n/m −798.37% (below 0%: shrinking) 44.11% (8.64%) Compare
DH Definitive Healthcare Corp. $163.7M — (loss-making) — (loss-making) −8.99% (below 0%: shrinking) n/m −32.60% (below 0%: shrinking) 77.27% (9.09%)
OPRX OptimizeRx Corp. $163.3M 35.8× 41.7× −29.77% (below 0%: shrinking) n/m +89.86% (above 0%: growing) 76.51% (0.43%) Compare
HCAT Health Catalyst, Inc. $112.9M — (loss-making) — (loss-making) −26.26% (below 0%: shrinking) n/m +65.58% (above 0%: growing) 42.71% 89.08% Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $91.8M 16.5× 11.0× +8.56% (above 0%: growing) +150.00% (above 0%: growing) −0.44% (below 0%: shrinking) 50.46% 19.50% Compare
Median of peers $170.5M 16.5× 14.5× −3.05% — +35.54% 63.36% 4.33%

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 23 April 2026

Ownership

Directors and executive officers, together 17.10% of the votes
Funds managed by Advent International, L.P., a Delaware limited partnership (f/k/a Advent International Corporation) 41.00% of the votes
Jason Krantz 15.60% of the votes
Affiliates of Spectrum Equity 10.60% of the votes
Goldman Sachs 4.10% of the votes
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Definitive Healthcare Corp. (DH) Latest News

17 Aug

Impact 4 · · The Motley Fool transcript

28 Jan

Impact 3 · · Simply Wall St.

19 Dec

Impact 3 · · Simply Wall St.
stockrow.com/DH · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com